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The purpose of this study was (1) to determine frequency and type of medication errors (MEs), (2) to assess the number of MEs
prevented by registered nurses, (3) to assess the consequences of ME for patients, and (4) to compare the number of MEs reported
by a newly developed medication error self-reporting tool to the number reported by the traditional incident reporting system.We
conducted a cross-sectional study on ME in the Cardiovascular Surgery Department of Bern University Hospital in Switzerland.
Eligible registered nurses (𝑛 = 119) involving in the medication process were included. Data on ME were collected using an
investigator-developed medication error self reporting tool (MESRT) that asked about the occurrence and characteristics of ME.
Registered nurseswere instructed to complete aMESRT at the end of each shift even if therewas noME.AllMESRTswere completed
anonymously. During the one-month study period, a total of 987MESRTs were returned. Of the 987 completedMESRTs, 288 (29%)
indicated that there had been an ME. Registered nurses reported preventing 49 (5%) MEs. Overall, eight (2.8%) MEs had patient
consequences.The high response rate suggests that this newmethodmay be a very effective approach to detect, report, and describe
ME in hospitals.
1. Introduction
Adverse events (AEs) caused by medication errors (MEs)
continue to be one of the great challenges in acute care
settings. Recent data suggest that each year more than 1.5
million patients are harmed byME in the United States [1]. A
substantial body of evidence confirms the risk resulting from
ME [2–6]. According to the report “Preventing Medication
Errors,” ME affect approximately 5% to 10% of patients in
the United States and cause more than 7000 deaths annually
[1].
The definition of ME remains inconsistent although
attempts to develop an international definition have been
made [7].TheNational Coordinating Council forMedication
Error Reporting and Prevention (NCC MERP) states that
“A medication error is any preventable event that may cause
or lead to inappropriate medication use or patient harm
while the medication is in the control of the health care
professional, patient, or consumer. Such events may be related
to professional practice, health care products, procedures, and
systems, including prescribing; order communication; product
labeling, packaging, and nomenclature; compounding; dispens-
ing; distribution; administration; education; monitoring; use”
[8].
Studies conducted in various healthcare settings report
medication error rates between 19–70%, depending on
research methodology [7, 9–13]. High rates continue to
exist despite increased levels of awareness about ME inso
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healthcare over the past decade and new developments
in technology designed to reduce such errors [14]. One
large study analysing when in the medication process ME
occurred found that 39% of errors occurred during ordering,
38% during medication administration, 12% during order
transcription, and 11% during medication dispensing [15].
Barker and colleagues reported that every fifth medication
dose administered resulted in an error, including the wrong
time of administration (43%), omission of a dose (30%),
wrong dosage (17%), and other errors (10%) [16].
Cardiovascular medications have been cited as one of
the most common classes of drugs associated with ME [2,
4, 15, 17]. LaPointe and Jollis detected a medication error
prevalence rate of 32% in cardiovascular patients. In more
than 40% of those MEs, cardiovascular medications were
involved [17]. The Adverse Drug Event Prevention Study
Group reported 2.4 odds of severe adverse drug events from
cardiovascular medications compared to other medications
[2, 4, 15]. Hence, ME in cardiovascular settings need special
attention, and it can be assumed that cardiovascular patients
are at an increased risk for negative consequences from
ME. However, the exact rate of ME is difficult to determine
due to varying methods of error reporting and calculating
error rates. These differences make it difficult to compare
data from different studies of ME. The information used to
decide whether errors occurred depends strongly on the way
in which the information is gathered, and many different
methods have been used [18–21]. Examples of methods
utilized to collect data on medication errors include critical
incidence reporting systems (CIRSs), generally anonymous
self-reporting tools used for ME reporting and analysis
[22]; incidence reports which typically involve health care
providers actively recording information on events [23];
direct observation; trigger tools; chart review; surveys of from
health professionals or patients regarding drug related events.
These methods can be complementary, and a combination
may be useful [19, 20]. However, currently used methods like
incident reports or chart reviews are known to underestimate
the incidence of ME. Furthermore, most existing tools are
not specifically designed to measure ME and may therefore
miss certain types of ME. Since no data about pragmatic,
easy to use, and low price ME reporting tools exist, new ME
reporting approaches—focussing just on ME reporting—are
ardently needed.
After an exhausting literature search, no studies utilizing
a specific ME self reporting tool—aiming to report ME
anonymously—could be identified. To close this gap, we
conducted the first ME reporting study according to a novel
method in a Swiss cardiovascular surgery department.
The purpose of this study was to examine ME events in a
cardiovascular surgery department of a tertiary level hospital
using a new medication error reporting method.
The specific aims of the study were (1) to determine
frequency and type of ME, (2) to assess the number of MEs
prevented by registered nurses, (3) to assess the consequences
of ME for patients, and (4) to compare the number of
MEs reported by a newly developed medication error self
reporting tool to the number reported by the traditional
incident reporting system.
2. Methods
2.1. Design. ACross-sectional study designwas used to assess
medication error events.
2.2. Setting and Sample. The study was conducted in the Car-
diovascular Surgery Department of the University Hospital
of Bern, Switzerland. The department consists of five units
including 60 patient beds. A convenience sample of registered
nurses (RNs) involved in direct patient care was recruited. All
RNs (𝑛 = 119) working on the units during the data collection
period were eligible to participate in the study. The mean age
of the RNs was 36 years (SD 10.8).Themean work experience
was 9.5 years (SD 9.0), and the mean work experience in the
cardiovascular surgery setting was 5.6 years (SD 5.0).
2.3. Variables. The outcome variables of interest in this study
were (1) ME frequency and type, (2) ME prevention by RNs,
and (3) ME consequences for patients.
2.4. Unit of Analysis. To calculate the incidence ofME during
the one-month study period the unit of analysis in this
study was the number of administered medication doses.
The amount of administered doses during the data collection
periodwas calculated retrospectively bymedical chart review.
2.5. Medication Process and Definition. According to Aspden
[1], the medication process is a five-step process that encom-
passes ordering, transcribing, preparing, administering, and
monitoring. The clinical medication use process in the study
department is in line with this five-step process, and the
RNs in our department are responsible in all steps but the
ordering.
After a physician ordered a medication regime for a
patient, nurses proofread the prescription, transcribe the
handwritten medication orders into a separate medical chart,
prepare themedication, according to thewritten information,
administer the medication and monitor the effects after the
patient receives the medication.
In our study, we have considered MEs as errors that
occurred during ordering, transcription of the order, and
during medication administration. Categories of medication
errors were further defined as follows:
(1) wrong order: any order that was illegible, incomplete
(missing of dosage, medication name, and intended
administration method), or wrong (wrong prescrip-
tion in terms of medication name, dosage, or admin-
istration method). If an RN detects an ordering error,
the nurse needs to clarify the order with the physician
who was involved;
(2) wrong transcription: any medication order that was
transcribed incorrectly from the physician’s ordering
sheet to a patient’s medical chart by an RN;
(3) wrong administration: any medication administra-
tion that deviates from at least one of the five rights
(right patient, right medication, right dose, right
route, and right time).
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Table 1:Themedication error self reporting tool (MESRT) to report
medication error events.
During my shift, one of the following medication error-related
events occurred (please mark with a cross)
(1) ◻ I administered a wrong medication to a patient
(2) ◻ I administered amedication at the wrong time
(more than 30 minutes earlier or later than ordered)
(3) ◻ I administered amedication in a wrong dosage
(4) ◻ I administered amedication to the wrong patient
(5) ◻ I administered amedication the wrong route
(6) ◻ A medication prescription was illegible
(7) ◻ A medication prescription was incomplete
(8) ◻ A medication prescription was wrong
(9) ◻ A medication prescription was transcribed wrong
(10) ◻Themedication error event had no consequences for
the patient
(11) ◻Themedication error event had consequences for the patient
→ If yes, what consequences? (use the space below)
(12) ◻ I realised that there is an error involved, but I was able to
prevent the error before it happened or resulted in patient
harm
→ If yes, what kind of error could be prevented? (use the
space below)
(13) ◻ No medication error-related event happened to me during
my shift
◻Morning shift ◻ Evening shift ◻ Night shift
Date:
2.6. Measurement. To report ME events, we developed a spe-
cific medication error self reporting tool (MESRT) according
the study purposes. This tool was composed of 13 items that
collected specific data on ME frequency and type (such as
errors during the ordering, transcribing, preparing, admin-
istering, and monitoring phases), ME prevented by RNs, and
patient consequences attributable to ME events (Table 1).
This MESRT is a unique reporting method focussing
specifically on ME events rather than addressing a variety of
adverse events which might occur in hospitals. The MESRT
consists of items to capture errors in the medication use
process only. Moreover, we developed theMESRT as a pocket
size booklet with 50 sheets (with instructions to complete one
for ME event or if there were no errors to complete one at
the end of the shift) each. Every registered nurse received
a booklet and was instructed to report all MEs after they
occurred. Finally, the MESRT allowed nurses to report MEs
anonymously.
2.7. Content Validity Testing. Prior to the study, the MESRT
was pilot tested with a focus group of 10 randomly selected
RNs from the participating cardiovascular surgery units
to evaluate its content validity. We calculated the content
validity index (CVI), a method used to quantify content
validity of multi-item scales [24].
A CVI can be computed for each item (I-CVI) on a given
scale as well as for the entire scale (S-CVI). To calculate the I-
CVI, all participating RNs were asked to rate the relevance
of each MESRT item, using a 4-point likert scale (1 = not
relevant, 2 = somewhat relevant, 3 = quite relevant, and 4 =
highly relevant).Then, for each item, the I-CVIwas computed
as the number of nurses giving a rating of either 3 or 4, divided
by the number of nurses rating the item. The average S-CVI
was computed by adding all I-CVIs and dividing this sum
by the total number of items (𝑛 = 13). An average S-CVI
of 0.90 or higher is considered to indicate excellent content
validity [24]. Our pretest resulted in an average S-CVI of 0.93,
reflecting an excellent content validity.
2.8. Data Collection Method. RNs were informed about the
purpose of the study and how to use the MESRT to report
ME events. The principle investigator reviewed the 13 items
included in the MESRT and how to respond to them with
each of the participating RNs to minimize reporting bias.
Nurses were informed by the principle investigator during
information rounds one week before the data collection
phase. During the data collection period, information rounds
were offered daily.
Prior to data collection, each RN received a standardized
pocket size booklet with 50 MESRT reporting sheets. RNs
were instructed to complete MESRT after each medication
error and, if there were no errors during their shift, to
complete one indicating that there had been no errors at
the end of their shift. Consequently, each RN completed a
MESRT at the end of their shift regardless of whether an
ME occurred or not. If more than one ME event occurred
during the shift, the RN completed a MESRT for each
event. CompletedMESRTs were dropped in the study-box on
every unit. No personal identifying data were collected. Data
collection took place from October 1st to 31st of 2009. The
MESRTwas used in addition to the hospital’s critical incident
reporting system (CIRS) which is used to voluntarily report
AEs including those in the cardiovascular department. In the
cardiovascular surgery department, CIRS was implemented
in 2006. All RNs were informed that their CIRS reporting
practice was not to be interrupted during the one-month
study period and that all AEs should be reported through
CIRS as usual, independently of completing the MESRT.
2.9. Data Analysis. Collected MESRT data were entered into
SPSS for Windows (V16.0, SPSS, Inc., Chicago, IL) by the
principle investigator. To determine ME frequency and type,
number of MEs prevented by RNs, and patient consequences
attributable to ME, data were analyzed using descriptive
statistic methods (frequencies, percentages, means, and stan-
dard deviations).
2.10. Ethical Considerations. As voluntary reporting and
disclosure of ME may pose a highly sensitive issue among
health care professionals, identity protection and confidential
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Table 2: Types, frequencies, and categories of medication errors.
Type of medication error 𝑁 (%) Category
Wrong time 139 (48.3) C
Wrong transcription 38 (13.2) B
Incomplete prescription 33 (11.5) A
Illegible prescription 32 (11.0) A
Wrong dose 20 (7.0) C
Wrong prescription 19 (6.6) A
Wrong medication 6 (2.1) C
Wrong route 1 (0.4) C
Wrong patient 0 (0) C
A: ordering error; B: transcribing error; C: administration error.
use of data were guaranteed. Participants provided written
informed consent prior to the data collection, and self-
reporting was voluntary during data collection. Our study
was approved by the Ethical Board of the Canton of Bern.
3. Results
During the one-month study period, a total of 24, 617 med-
ication doses were administered to cardiovascular patients.
During this timeframe, 288 MEs were reported on MESRTs.
The incidence ofME in this study was 1.2% based on reported
ME in relation to the total administered medication doses.
A total of 987 MESRTs were returned (response rate
84%). In fact, 650 (66%) RNs reported that no ME occurred
during their shift. A total of 288 of the MESRTs (29%)
reported an ME. RNs reported preventing 49 MEs (5% of
completed MESRTs). Of the 288 reported MEs, eight (2.8%)
revealed information thatMEhad a consequence for a patient
such as extra patient monitoring and increased surveillance
frequency. However, no patient experienced harmful or life
threatening ME consequences during the study period.
The most frequently reported type of ME in our study
was administering the medication at the wrong time (48.3%).
MEs were categorized as errors that occurred when the
medication was ordered, during transcription of the order,
and during medication administration (Table 2). Twenty-
nine percent of MEs occurred during ordering, 13% during
transcription, and 58% during medication administration.
Comparatively, during the study period, sevenME events
were reported in the CIRS of the cardiovascular surgery
department. The reported CIRS cases were transcription
and administration errors and were categorized as follows:
transcription errors (𝑛 = 2), wrong dose (𝑛 = 3), wrong time
(𝑛 = 1), and wrong medication (𝑛 = 1).
4. Discussion
In this study, we successfully implemented a novel reporting
method—a medication error self reporting tool (MESRT)—
to examine the frequency and type ofME, their consequences
for patients and the number of MEs prevented by RNs.
The overall ME incidence in our study was 1.2%. ME
incidence was calculated based on number of reported MEs
relative to the total number ofmedication doses administered
during the study period. If the patient had been the unit
of analysis, ME frequency would probably be significantly
higher. Hence, the methodological approach must be con-
sidered when interpreting these findings [18]. Most MEs
reported with the MESRT were medication administration
errors (58%) followed by ordering errors (29%) and tran-
scription errors (13%). Our results on ME types are similar
to results of Leape and colleagues who indicated that 49%
of MEs occurred during administration of medications, 39%
occurred during physician ordering, and 12% during the
transcription phase [15]. Bates and colleagues reported that
56% of MEs occurred during the ordering stage, 6% during
transcription, and 34% during medication administration
[2]. Our results are in line with these data.
Detected MEs were mainly medication administration
errors followed by ordering and transcription errors. All
medication orders were handwritten by physicians and tran-
scribed by an RN. Transcription errors accounted for 12% of
the reported MEs. One effective strategy to reduce ordering
and transcription errors may be the use of a computerized
physician ordering entry system combined with barcode
medication administration record [3, 25–28].
Among all medication administration errors, time errors
were the most prevalent. For the purpose of this study, a
time error was defined as administering a medication more
than 30 minutes before or after its scheduled administration
time. Hence, the high rate of time errors may be related
to the timeframe used. Unfortunately, there is no broad
agreement in the literature regarding what constitutes early
or late medication administration [16, 28, 29].
According to all analyzed MESRTs, 5% of potential ME
were prevented by RNs. This is surprising since RNs could
be seen as last barriers before a medication reach a patient.
However, the reason for this relatively low rate may be the
self reporting method utilized in this study.
No ME reported in our study had a negative impact on
patients’ health. No patient was harmed by a medication.
Hence, no patients experienced an adverse drug event (ADE),
although cardiovascular patient are at high risk for negative
consequences from ME. In contrast, Bates et al. reported an
ADE rate of 6.5%, with 7% of ME judged to be associated
with potential ADEs [2]. Similarly, Hardmeier and colleagues
reported that 7.5% of patients experienced an ME-associated
ADE during hospitalisation [30].
During the timeframe of this study, manymoreMEs were
reported with theMESRT (𝑛 = 288) than with the traditional
CIRS (𝑛 = 7). Our findings are similar to the findings
of other studies and support the argument that reporting
attitudes may vary greatly, depending on the ME assessment
methods used [7, 18, 20, 31, 32]. Moreover, the findings
suggest that CIRS may not reliably measure the prevalence
of ME. However, various other factors such as disparities in
ME definition, terminology, and unequal reporting toolsmay
influence ME reporting [7, 13, 19, 33].
The remarkable disparity between theMEs captured with
the MESRT and those reported by CIRS might be a crucial
finding concerning error reporting accuracy and should be
considered when designing ME reporting methods in the
Nursing Research and Practice 5
future. Our data show that it is important to use simple
reporting tools which facilitateME reporting. Clearly defined
ME reporting standards and measurement tools are needed
to facilitate ME reporting and to ensure data accuracy [15, 31,
34].
The findings of this study suggest that our MESRT
may facilitate ME reporting substantially. The MESRT we
developed is easy to use, and it is clear for RNs what
to report as an ME. No login into a computer system is
required to complete a MESRT. Some RNs may have been
concerned that by requiring computer login to report an
ME through CIRS, reporting was not truly anonymous. The
MESRT used in this study respects anonymous reporting
rigorously. The standardized pocket size booklet allows an
RN to anonymously report an ME right after its occurrence.
By reporting the ME anonymously, fear of blame as a result
of reporting an error can be avoided. This is pivotal because
one of the overriding barriers to report adverse events is fear
of blame and punishment, depending on the existing safety
culture in an institution [35–39].
5. Limitations
Although this was the first study to systematically report
ME in a Swiss cardiovascular hospital setting with a new
ME reporting method, potential limitations have to be con-
sidered. First, the study was conducted over a short period
of time which may not have been representative of usual
medication error events. Second, the reporting of ME with
a customized MESRT may represent some degree of under-
reporting due to the fact that not all MEs are consciously
detected by RNs. In addition, medication omission errors
and administering unauthorized drugs were not captured by
the MESRT. Finally, the results must be carefully interpreted.
All of the nurses worked in one cardiovascular surgery
department. Findings may, therefore, not be generalized to
other units and hospitals. However, our study does provide a
snapshot of ME within a given period of time and suggests
that rates are probably much higher than those detected by
CIRS. This study should be replicated within a larger sample
and over a longer period of time in acute care settings. Despite
its limitations, this study demonstrated the successful use of
a novel ME reporting method that could provide insights
into the occurrence of ME and provide a basis for reviewing
medication safety procedures.
6. Conclusions
The results of this study are a novelty for Switzerland since
data on ME are sparsely available in Switzerland, and data
from cardiovascular departments are—to our knowledge—
nonexistent so far. Therefore, this is the first Swiss study that
utilized a specific MESRT to collect ME data.
During a one-month data collection period, 987MESRTs
were completed. Overall, 288 MEs were reported by RNs.
Relative to the total number of doses on medication admin-
istered during the time period of this study, the incidence of
ME was 1.2%.
Surprisingly, our novel approach had the potential to
detect significantly more MEs than the hospital CIRS. The
high response rate suggests that this new ME reporting tool,
for at least short-term monitoring, may be a very effective
approach to detect, report, and describe ME. The MESRT
we developed is a simple tool for RNs that appears to be
an acceptable method of reporting medication error events.
It detected many more MEs than usual incidence reporting
systems. Future studies should examine its utility in a larger
sample of nurses conducted over a longer period of time in
multiple hospitals and in combination with other medication
assessment methods such as direct observation. With respect
to further studies, it will be of great value to expand the
MESRTwithmore items asking about, for example, omission
errors and administration of unauthorized drugs.
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